JP Morgan Chase’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65M | Sell |
305,100
-600
| -0.2% | -$133K | ﹤0.01% | 1224 |
|
|
2025
Q4 | $69.8M | Sell |
305,700
-55,400
| -15% | -$12.6M | ﹤0.01% | 1149 |
|
|
2025
Q3 | $83.6M | Buy |
361,100
+44,600
| +14% | +$9.08M | 0.01% | 1088 |
|
|
2025
Q2 | $58.7M | Sell |
316,500
-197,600
| -38% | -$36.7M | ﹤0.01% | 1238 |
|
|
2025
Q1 | $108M | Sell |
514,100
-369,700
| -42% | -$71.9M | 0.01% | 891 |
|
|
2024
Q4 | $157M | Buy |
883,800
+87,700
| +11% | +$16.1M | 0.01% | 746 |
|
|
2024
Q3 | $157M | Buy |
796,100
+483,800
| +155% | +$90.3M | 0.01% | 771 |
|
|
2024
Q2 | $53.6M | Sell |
312,300
-147,800
| -32% | -$24.5M | ﹤0.01% | 1212 |
|
|
2024
Q1 | $83.8M | Buy |
460,100
+249,200
| +118% | +$42.9M | 0.01% | 1016 |
|
|
2023
Q4 | $32.7M | Buy |
210,900
+141,800
| +205% | +$20.7M | ﹤0.01% | 1476 |
|
|
2023
Q3 | $10.3M | Hold |
69,100
| – | – | ﹤0.01% | 2218 |
|
|
2023
Q2 | $9.31M | Sell |
69,100
-250,600
| -78% | -$36.7M | ﹤0.01% | 2344 |
|
|
2023
Q1 | $51M | Sell |
319,700
-759,900
| -70% | -$116M | 0.01% | 1096 |
|
|
2022
Q4 | $174M | Buy |
1,079,600
+203,800
| +23% | +$31.2M | 0.02% | 558 |
|
|
2022
Q3 | $118M | Buy |
875,800
+303,900
| +53% | +$43.6M | 0.02% | 659 |
|
|
2022
Q2 | $87.6M | Buy |
571,900
+19,700
| +4% | +$3.01M | 0.01% | 795 |
|
|
2022
Q1 | $89.5M | Buy |
552,200
+87,500
| +19% | +$12.7M | 0.01% | 884 |
|
|
2021
Q4 | $62.9M | Buy |
464,700
+155,900
| +50% | +$18.4M | 0.01% | 1092 |
|
|
2021
Q3 | $33.3M | Buy |
308,800
+208,000
| +206% | +$23.8M | ﹤0.01% | 1404 |
|
|
2021
Q2 | $11.4M | Buy |
100,800
+82,700
| +457% | +$9.31M | ﹤0.01% | 2320 |
|
|
2021
Q1 | $1.96M | Sell |
18,100
-237,700
| -93% | -$25.4M | ﹤0.01% | 3743 |
|
|
2020
Q4 | $27.4M | Buy |
255,800
+40,500
| +19% | +$3.89M | ﹤0.01% | 1403 |
|
|
2020
Q3 | $18.7M | Sell |
215,300
-115,000
| -35% | -$10.8M | ﹤0.01% | 1539 |
|
|
2020
Q2 | $32.4M | Sell |
330,300
-120,500
| -27% | -$10.6M | 0.01% | 1081 |
|
|
2020
Q1 | $34.3M | Buy |
450,800
+219,200
| +95% | +$18.7M | 0.01% | 961 |
|
|
2019
Q4 | $20.5M | Sell |
231,600
-180,900
| -44% | -$15M | ﹤0.01% | 1574 |
|
|
2019
Q3 | $31.2M | Buy |
412,500
+12,500
| +3% | +$857K | 0.01% | 1252 |
|
|
2019
Q2 | $28M | Buy |
400,000
+4,600
| +1% | +$362K | 0.01% | 1326 |
|
|
2019
Q1 | $31.9M | Buy |
395,400
+141,100
| +55% | +$11.5M | 0.01% | 1215 |
|
|
2018
Q4 | $23.4M | Hold |
254,300
| – | – | 0.01% | 1367 |
|
|
2018
Q3 | $24.1M | Buy |
254,300
+109,600
| +76% | +$10.4M | ﹤0.01% | 1521 |
|
|
2018
Q2 | $13.4M | Sell |
144,700
-95,000
| -40% | -$9.28M | ﹤0.01% | 1907 |
|
|
2018
Q1 | $22.7M | Sell |
239,700
-527,400
| -69% | -$57.9M | ﹤0.01% | 1423 |
|
|
2017
Q4 | $74.2M | Buy |
767,100
+210,300
| +38% | +$19.8M | 0.02% | 788 |
|
|
2017
Q3 | $49.5M | Buy |
556,800
+33,800
| +6% | +$2.57M | 0.01% | 934 |
|
|
2017
Q2 | $37.9M | Sell |
523,000
-244,950
| -32% | -$16.5M | 0.01% | 1064 |
|
|
2017
Q1 | $50M | Buy |
767,950
+27,550
| +4% | +$1.73M | 0.01% | 948 |
|
|
2016
Q4 | $46.4M | Buy |
740,400
+592,586
| +401% | +$36.2M | 0.01% | 937 |
|
|
2016
Q3 | $9.32M | Sell |
147,814
-8,430,000
| -98% | -$546M | ﹤0.01% | 1844 |
|
|
2016
Q2 | $531M | Buy |
8,577,814
+8,553,814
| +35,641% | +$521M | 0.13% | 176 |
|
|
2016
Q1 | $1.37M | Sell |
24,000
-190,700
| -89% | -$10.6M | ﹤0.01% | 2905 |
|
|
2015
Q4 | $12.7M | Buy |
214,700
+139,700
| +186% | +$8.05M | ﹤0.01% | 1657 |
|
|
2015
Q3 | $4.08M | Buy |
75,000
+48,800
| +186% | +$3.18M | ﹤0.01% | 2349 |
|
|
2015
Q2 | $1.76M | Sell |
26,200
-38,800
| -60% | -$2.53M | ﹤0.01% | 2975 |
|
|
2015
Q1 | $3.81M | Sell |
65,000
-233,500
| -78% | -$14.1M | ﹤0.01% | 2526 |
|
|
2014
Q4 | $19.5M | Buy |
298,500
+243,500
| +443% | +$15.4M | ﹤0.01% | 1483 |
|
|
2014
Q3 | $3.18M | Buy |
+55,000
| New | +$3.05M | ﹤0.01% | 2635 |
|
|
2014
Q1 | – | Sell |
-30,700
| Closed | -$1.62M | – | 3550 |
|
|
2013
Q4 | $1.62M | Buy |
30,700
+5,700
| +23% | +$280K | ﹤0.01% | 2885 |
|
|
2013
Q3 | $1.12M | Buy |
+25,000
| New | +$1.11M | ﹤0.01% | 3197 |
|
Other funds holding ABBV
VCM
VPM
JP Morgan Chase's ABBV Position: Q1 2026 in Review
JP Morgan Chase increased its AbbVie (ABBV) stake by 8.3% in Q1 2026, buying an estimated $965M and bringing the position to 56,741,691 shares worth $12.1B. The position accounts for 0.78% of the portfolio, ranked #19.
JP Morgan Chase first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.1B in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- JP Morgan Chase held 56,741,691 shares of AbbVie worth $12.1B as of Q1 2026.
- JP Morgan Chase bought 4,348,368 AbbVie shares in Q1 2026, an estimated $965M.
- AbbVie made up 0.78% of JP Morgan Chase's portfolio in Q1 2026, its #19 holding.
- JP Morgan Chase first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's AbbVie position peaked at $13.1B in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.